FDA Inspection 1084841 — Stanislaw Mazur, M.D.
The FDA completed an inspection of Stanislaw Mazur, M.D. on Mar 4, 2019 in Rzeszow. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 4, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rzeszow (Poland)
Additional Details
Clinical Investigator (CI)